Ethical Challenges of Consent in Data Sharing

Data Sharing Clinical Trial

— Data Sharing  

Official title:

Ethical Challenges Related to Consent Following Implementation of a New Data Sharing Policy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03346720
• Other study ID #: BE1601
• Status: Completed
• Start date: February 1, 2017
• Est. completion date: August 7, 2017

Study information

• Verified date: June 2018
• Source: University of Oxford
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

In recent years, Mahidol Oxford Tropical Medicine Research Unit (MORU) has coordinated some of the largest international studies involving many sites in low-income and hard-to-reach settings. It has been our policy for many years to support sharing of data across collaborative research networks in order to maximize their utility. However there is increasing support from research funders, regulatory agencies and journals for sharing individual-level data from genomic, medical and public health research beyond research collaborations. A number of potential advantages of sharing individual level data from clinical and public health research have been identified in the literature. These include maximizing the utility of data, allowing verification of research results, and minimizing the burdens and costs of unnecessary duplication of research. In low- and middle-income settings it may be particularly important to effectively share data to maximize its utility and enable timely responses to important public health issues such as resistance to antimalarial treatments. Many authors have called for data sharing to be carefully curated, to minimize potential harms including breaches of privacy, the publication of poor quality or biased secondary research, and insufficient acknowledgment of the contribution of researchers generating datasets. In low- and middle-income settings, the need for data sharing policies and processes to promote equitable use of data, including the development of sustainable capacity to both share and analyse datasets, has been recognized.

It is foreseeable that the impact of this policy will be significant both practically and ethically. In the practical sense, there have already been changes in our data management processes and resources, clinical trial agreements and negotiations with collaborators. Ethically, this policy has impact on the consent process which includes the increasing use of broad consent, the changes in the language of information sheets, study protocols and ethics application documents and the actual consent taking by research staff.

Now that that these new data-sharing mechanisms have been put in place there is a need to evaluate their impact on practice. The aim of this study is to identify and analyse ethical challenges related to consent following implementation of a new data sharing policy with the aim of refining the data sharing policy and its related consent processes

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: August 7, 2017
• Est. primary completion date: August 7, 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Participant is willing and able to give informed consent for participation in the study.

• Male or female, aged 18 years or above.

• Able to speak and understand Thai, English, Burmese or Karen

Exclusion Criteria:

• Lack of relevant experience or expertise

Related Conditions & MeSH terms

• Data Sharing

Intervention

Other:
• Semi-structured interviews
These interviews will be conducted following an interview guide. Interviews will be conducted in English or Thai at a place convenient and familiar to the interviewee. It is estimated that each interview will last between 45 minutes to an hour.
• Focus group discussions (FGDs)
These will be conducted following an interview guide. FGDs will be conducted in English or Thai. In addition, a note taker will be present to take notes. FGDs will take place at a place convenient and familiar to the participants. It is estimated that each FGD will last between 1 to 1.5 hours. FGDs will typically consist of homogenous groups e.g. study nurses.

Locations

Country	Name	City	State
Thailand	Hospital for tropical diseases, Faculty of Tropical Medicine, Mahidol University	Bangkok
Thailand	Mahidol-Oxford Tropical Medicine Research Unit (MORU) Office	Bangkok
Thailand	Shoklo Malaria Research Unit, Mae Sot	Mae Sot	Tak

Sponsors (1)

Lead Sponsor	Collaborator
University of Oxford

Country where clinical trial is conducted

Thailand, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The opinion of ethical challenges in consent process under a new data sharing policy		1 year
Secondary	The opinion of participants recruited in primary research with information presented to potential participations in future research studies about data sharing		1 year
Secondary	The views of stakeholders with broad consent		1 year